In October that year, Novo also petitioned the FDA to add semaglutide to the regulators Demonstrable Difficulties for Compounding, which enumerates drugs that are too complex to be compounded and which could result in substantial safety risks if incorrectly manufactured
If more than 5 days have passed since your scheduled dose, skip the missed injection entirely and take your next dose on the originally scheduled day do not double-dose to catch up, as this significantly increases nausea and vomiting risk without improving therapeutic benefit
People allergic to Semaglutide base, those with Medullary Thyroid Carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), severe digestive disorders, or Diabetic Ketoacidosis should avoid Sembolic Injection unless specifically advised by a healthcare provider
The answer depends on three things: Whether the vial is opened or unopened The exact room temperature How long was it exposed
GLP-1 Receptor Agonists StatPearls